NARG1L Antikörper (Middle Region)
Kurzübersicht für NARG1L Antikörper (Middle Region) (ABIN630806)
Target
Alle NARG1L (NAA16) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- NARG1 L antibody was raised against the middle region of NARG1
-
Aufreinigung
- Affinity purified
-
Immunogen
- NARG1 L antibody was raised using the middle region of NARG1 corresponding to a region with amino acids ASLKTCDFFSPYENGEKEPPTTLLWVQYFLAQHFDKLGQYSLALDYINAA
-
-
-
-
Applikationshinweise
-
WB: 0.5 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
NARG1L Blocking Peptide, catalog no. 33R-1516, is also available for use as a blocking control in assays to test for specificity of this NARG1L antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of NARG0 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- NARG1L (NAA16) (N(alpha)-Acetyltransferase 16, NatA Auxiliary Subunit (NAA16))
-
Andere Bezeichnung
- NARG1L
-
Hintergrund
- NARG1L may belong to a complex displaying N-terminal acetyltransferase activity.
-
Molekulargewicht
- 50 kDa (MW of target protein)
Target
-